Dare Bioscience Stock Alpha and Beta Analysis
| DARE Stock | USD 2.17 0.01 0.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Dare Bioscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Dare Bioscience over a specified time horizon. Remember, high Dare Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Dare Bioscience's market risk premium analysis include:
Beta 1.83 | Alpha 0.005183 | Risk 4.18 | Sharpe Ratio 0.0344 | Expected Return 0.14 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Dare Bioscience Backtesting, Dare Bioscience Valuation, Dare Bioscience Correlation, Dare Bioscience Hype Analysis, Dare Bioscience Volatility, Dare Bioscience History and analyze Dare Bioscience Performance. Dare Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Dare Bioscience market risk premium is the additional return an investor will receive from holding Dare Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Dare Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Dare Bioscience's performance over market.| α | 0.01 | β | 1.83 |
Dare Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Dare Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how Dare Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Dare Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Dare Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dare Bioscience shares will generate the highest return on investment. By understating and applying Dare Bioscience stock market price indicators, traders can identify Dare Bioscience position entry and exit signals to maximize returns.
Dare Bioscience Return and Market Media
Price Growth (%) |
| Timeline |
About Dare Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Dare or other stocks. Alpha measures the amount that position in Dare Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Dare Bioscience Upcoming Company Events
As portrayed in its financial statements, the presentation of Dare Bioscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dare Bioscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Dare Bioscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Dare Bioscience. Please utilize our Beneish M Score to check the likelihood of Dare Bioscience's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Dare Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Dare Bioscience Backtesting, Dare Bioscience Valuation, Dare Bioscience Correlation, Dare Bioscience Hype Analysis, Dare Bioscience Volatility, Dare Bioscience History and analyze Dare Bioscience Performance. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Dare Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.